المؤلفون: A.L. Fonder, Neil E. Kay, W.J. Archibald, J.F. Leis, S.A. Parikh, E. Muchtar, B.F. Kabat, T.G. Call, A.B. Koehler, Kari G. Rabe, S.S. Kenderian, Susan M. Schwager, Susan L. Slager, W. Ding

المصدر: HemaSphere. 3:144-145

مصطلحات موضوعية: Oncology, medicine.medical_specialty, chemistry.chemical_compound, chemistry, business.industry, Internal medicine, Ibrutinib, Chronic lymphocytic leukemia, Medicine, In patient, Hematology, business, medicine.disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::51a394ec6638049686c503bb3ed4e8b7
https://doi.org/10.1097/01.hs9.0000559752.36194.44